Literature DB >> 11285037

The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.

E I Kohorn1.   

Abstract

The classification of the International Federation of Obstetrics and Gynecology (FIGO) for Trophoblastic Disease was changed at the meeting in Washington in September 2000 by combining the basic FIGO anatomic staging with the modified World Health Organization (WHO) risk factor scoring system. This presentation outlines the new system and provides a critical evaluation of the issues that have been resolved and those that are still outstanding.

Entities:  

Mesh：

Year:  2001        PMID： 11285037     DOI： 10.1046/j.1525-1438.2001.011001073.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


  25 in total

1.  Management of molar pregnancy.

Authors:  Alessandro Cavaliere; Santina Ermito; Angela Dinatale; Rosa Pedata
Journal:  J Prenat Med       Date:  2009-01

2.  Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.

Authors:  Xing-Zheng Zheng; Xu-Ying Qin; Su-Wen Chen; Peng Wang; Yang Zhan; Ping-Ping Zhong; Natalia Buza; Yu-Lan Jin; Bing-Quan Wu; Pei Hui
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

Review 3.  Gestational trophoblastic neoplasia: the management of relapsing patients and other recent advances.

Authors:  Naveed Sarwar; Edward S Newlands; Michael J Seckl
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

4.  Choriocarcinoma with Uterine Rupture and Shock: A Rare Case Report.

Authors:  Manika Agarwal; Ritesh Kumar; Jupirika Pyrbot; A S Singh
Journal:  J Clin Diagn Res       Date:  2015-10-01

5.  The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review.

Authors:  Monika M Skubisz; Stephen Tong
Journal:  ISRN Obstet Gynecol       Date:  2012-02-19

6.  Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease.

Authors:  L Walkington; J Webster; B W Hancock; J Everard; R E Coleman
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

7.  Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.

Authors:  Roshan Agarwal; Suliana Teoh; Delia Short; Richard Harvey; Philip M Savage; Michael J Seckl
Journal:  Lancet       Date:  2011-11-28       Impact factor: 79.321

8.  Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements.

Authors:  B You; R Harvey; E Henin; H Mitchell; F Golfier; P M Savage; M Tod; M Wilbaux; G Freyer; M J Seckl
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

9.  NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges.

Authors:  Rima Slim; Evan P Wallace
Journal:  Front Immunol       Date:  2013-08-20       Impact factor: 7.561

10.  Uterine rupture due to invasive metastatic gestational trophoblastic neoplasm.

Authors:  David I Bruner; Amy M Pritchard; Jonathan Clarke
Journal:  West J Emerg Med       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.